188 related articles for article (PubMed ID: 17010618)
1. Discovery of novel, highly potent and selective beta-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles.
DeMarco SJ; Henze H; Lederer A; Moehle K; Mukherjee R; Romagnoli B; Robinson JA; Brianza F; Gombert FO; Lociuro S; Ludin C; Vrijbloed JW; Zumbrunn J; Obrecht JP; Obrecht D; Brondani V; Hamy F; Klimkait T
Bioorg Med Chem; 2006 Dec; 14(24):8396-404. PubMed ID: 17010618
[TBL] [Abstract][Full Text] [Related]
2. Beta-hairpin peptidomimetics: design, structures and biological activities.
Robinson JA
Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
[TBL] [Abstract][Full Text] [Related]
3. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D
Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832
[TBL] [Abstract][Full Text] [Related]
4. Peptide-lead CXCR4 antagonists with high anti-HIV activity.
Fujii N; Tamamura H
Curr Opin Investig Drugs; 2001 Sep; 2(9):1198-202. PubMed ID: 11717804
[TBL] [Abstract][Full Text] [Related]
5. A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.
Tamamura H; Xu Y; Hattori T; Zhang X; Arakaki R; Kanbara K; Omagari A; Otaka A; Ibuka T; Yamamoto N; Nakashima H; Fujii N
Biochem Biophys Res Commun; 1998 Dec; 253(3):877-82. PubMed ID: 9918823
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship study of CXCR4 antagonists bearing the cyclic pentapeptide scaffold: identification of the new pharmacophore.
Tanaka T; Tsutsumi H; Nomura W; Tanabe Y; Ohashi N; Esaka A; Ochiai C; Sato J; Itotani K; Murakami T; Ohba K; Yamamoto N; Fujii N; Tamamura H
Org Biomol Chem; 2008 Dec; 6(23):4374-7. PubMed ID: 19005596
[TBL] [Abstract][Full Text] [Related]
7. Macrocyclic hairpin mimetics of the cationic antimicrobial peptide protegrin I: a new family of broad-spectrum antibiotics.
Shankaramma SC; Athanassiou Z; Zerbe O; Moehle K; Mouton C; Bernardini F; Vrijbloed JW; Obrecht D; Robinson JA
Chembiochem; 2002 Nov; 3(11):1126-33. PubMed ID: 12404639
[TBL] [Abstract][Full Text] [Related]
8. Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
Hegde R; Borkow G; Berchanski A; Lapidot A
FEBS J; 2007 Dec; 274(24):6523-36. PubMed ID: 18028446
[TBL] [Abstract][Full Text] [Related]
9. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.
Dong CZ; Kumar S; Choi WT; Madani N; Tian S; An J; Sodroski JG; Huang Z
J Med Chem; 2005 Dec; 48(25):7923-4. PubMed ID: 16335916
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1.
Catalano JG; Gudmundsson KS; Svolto A; Boggs SD; Miller JF; Spaltenstein A; Thomson M; Wheelan P; Minick DJ; Phelps DP; Jenkinson S
Bioorg Med Chem Lett; 2010 Apr; 20(7):2186-90. PubMed ID: 20194023
[TBL] [Abstract][Full Text] [Related]
11. Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.
Moncunill G; Armand-Ugón M; Clotet-Codina I; Pauls E; Ballana E; Llano A; Romagnoli B; Vrijbloed JW; Gombert FO; Clotet B; De Marco S; Esté JA
Mol Pharmacol; 2008 Apr; 73(4):1264-73. PubMed ID: 18182480
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical downregulation of CXC chemokine receptor 4 induced by polyphemusin II-derived antagonists.
Masuda R; Oishi S; Tanahara N; Ohno H; Hirasawa A; Tsujimoto G; Yano Y; Matsuzaki K; Navenot JM; Peiper SC; Fujii N
Bioconjug Chem; 2012 Jun; 23(6):1259-65. PubMed ID: 22486464
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4.
Bodart V; Anastassov V; Darkes MC; Idzan SR; Labrecque J; Lau G; Mosi RM; Neff KS; Nelson KL; Ruzek MC; Patel K; Santucci Z; Scarborough R; Wong RS; Bridger GJ; Macfarland RT; Fricker SP
Biochem Pharmacol; 2009 Oct; 78(8):993-1000. PubMed ID: 19540208
[TBL] [Abstract][Full Text] [Related]
14. Targeting HIV-1 through molecular modeling and docking studies of CXCR4: leads for therapeutic development.
Singh S; Malik BK; Sharma DK
Chem Biol Drug Des; 2007 Mar; 69(3):191-203. PubMed ID: 17441905
[TBL] [Abstract][Full Text] [Related]
15. Identification of a D-amino acid decapeptide HIV-1 entry inhibitor.
Boggiano C; Jiang S; Lu H; Zhao Q; Liu S; Binley J; Blondelle SE
Biochem Biophys Res Commun; 2006 Sep; 347(4):909-15. PubMed ID: 16854380
[TBL] [Abstract][Full Text] [Related]
16. A minimalistic 3D pharmacophore model for cyclopentapeptide CXCR4 antagonists.
Våbenø J; Nikiforovich GV; Marshall GR
Biopolymers; 2006; 84(5):459-71. PubMed ID: 16552740
[TBL] [Abstract][Full Text] [Related]
17. [Peptide-lead drug discovery].
Oishi S; Fujii N
Tanpakushitsu Kakusan Koso; 2007 Oct; 52(13 Suppl):1696-701. PubMed ID: 18051402
[No Abstract] [Full Text] [Related]
18. Anti-HIV-1 entry optimization of novel imidazopiperidine-tropane CCR5 antagonists.
Ernst J; Dahl R; Lum C; Sebo L; Urban J; Miller SG; Lundström J
Bioorg Med Chem Lett; 2008 Feb; 18(4):1498-501. PubMed ID: 18194864
[TBL] [Abstract][Full Text] [Related]
19. Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo.
Thoma G; Streiff MB; Kovarik J; Glickman F; Wagner T; Beerli C; Zerwes HG
J Med Chem; 2008 Dec; 51(24):7915-20. PubMed ID: 19053768
[TBL] [Abstract][Full Text] [Related]
20. Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents.
Miller JF; Turner EM; Gudmundsson KS; Jenkinson S; Spaltenstein A; Thomson M; Wheelan P
Bioorg Med Chem Lett; 2010 Apr; 20(7):2125-8. PubMed ID: 20207537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
